Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Equity

v3.8.0.1
Consolidated Statement of Equity - USD ($)
$ in Thousands
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-controlling Interest
Total
Balance at Dec. 31, 2014 $ 232 $ (13,242) $ 233,888   $ (19,443) $ 556 $ 201,991
Balance (in shares) at Dec. 31, 2014 46,345,376 (11,800,723)          
Increase (decrease) in shareholders' equity              
Exercise of stock options $ 5   8,274       8,279
Exercise of stock options (in shares) 1,047,911            
Issuance of common stock - vesting of restricted stock units $ 2           2
Issuance of common stock - vesting of restricted stock units (in shares) 434,292            
Acquisition of businesses $ 31   195,420       195,451
Acquisition of businesses (in shares) 6,097,836            
Acquisition of business - attribution of the fair market value of replacement award     4,318       4,318
Stock-based compensation expense     15,161       15,161
Excess tax benefit from stock-based compensation expense     17,607       17,607
Purchase of treasury stock for stock-based tax withholdings   $ (7,412)         (7,412)
Purchase of treasury stock for stock-based tax withholdings (in shares)   (145,566)          
Purchase of ERS units     58     (158) (100)
Foreign currency translation gain (loss)       $ (2)     (2)
Loss on foreign currency contracts designated as cash flow hedges reclassified to earnings       196     196
Net loss (income)         4,436   4,436
Balance at Dec. 31, 2015 $ 270 $ (20,654) 474,726 194 (15,007) 398 439,927
Balance (in shares) at Dec. 31, 2015 53,925,415 (11,946,289)          
Increase (decrease) in shareholders' equity              
Exercise of stock options $ 2   4,922       4,924
Exercise of stock options (in shares) 598,382            
Issuance of common stock - vesting of restricted stock units $ 6           6
Issuance of common stock - vesting of restricted stock units (in shares) 1,118,889            
Stock-based compensation expense     32,572       32,572
Excess tax benefit from stock-based compensation expense     4,455       4,455
Purchase of treasury stock for stock-based tax withholdings   $ (10,966)         (10,966)
Purchase of treasury stock for stock-based tax withholdings (in shares)   (412,220)          
Common stock shares repurchased   $ (1,448)         $ (1,448)
Common stock shares repurchased (in shares)   (43,610)         (43,610)
Foreign currency translation gain (loss)       (412)     $ (412)
Loss on foreign currency contracts designated as cash flow hedges reclassified to earnings       (204)     (204)
Net loss (income)         (55,567)   (55,567)
Balance at Dec. 31, 2016 $ 278 $ (33,068) 516,675 (422) (70,574) 398 413,287
Balance (in shares) at Dec. 31, 2016 55,642,686 (12,402,119)          
Increase (decrease) in shareholders' equity              
Exercise of stock options $ 4   7,947       7,951
Exercise of stock options (in shares) 837,857            
Issuance of common stock - vesting of restricted stock units $ 5           5
Issuance of common stock - vesting of restricted stock units (in shares) 969,513            
Stock-based compensation expense     31,635       31,635
Purchase of treasury stock for stock-based tax withholdings   $ (13,974)         $ (13,974)
Purchase of treasury stock for stock-based tax withholdings (in shares)   (347,296)          
Common stock shares repurchased (in shares)             0
Foreign currency translation gain (loss)       1,046     $ 1,046
Net loss (income)         (3,280)   (3,280)
Balance at Dec. 31, 2017 $ 287 $ (47,042) $ 556,257 $ 624 $ (73,854) $ 398 $ 436,670
Balance (in shares) at Dec. 31, 2017 57,450,056 (12,749,415)